Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 24Non-Muscle Invasive Bladder Neoplasms 5Hematuria 4Pain 2Carcinoma, Transitional Cell 2Carcinoma in Situ 2Urinary Bladder Neck Obstruction 1Urinary Bladder Diseases 1Urinary Bladder Calculi 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Pain, Postoperative 1Nephrolithiasis 1Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Lower Urinary Tract Symptoms 1Kidney Neoplasms 1Kidney Diseases 1Disease 1Anxiety Disorders 1

Interventions

pembrolizumab 28Docetaxel 21Gemcitabine 19Nivolumab 14Paclitaxel 13Prednisone 11Leuprolide 11pazopanib 10Radiotherapy 10Cisplatin 10Sunitinib 9Sorafenib 9Ipilimumab 8Blood Specimen Collection 8Bevacizumab 8avelumab 7Therapeutics 7Thalidomide 7Cyclophosphamide 7Carboplatin 7atezolizumab 6Standard of Care 6Radiation 6Mitomycin 6Interleukin-2 6Cetuximab 6Axitinib 6padeliporfin 5cemiplimab 5Radiosurgery 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Cystoscopy × Genitourinary × Clear all
NCT05796375 2026-05-04

ReplaceCysto

White River Junction Veterans Affairs Medical Center

Phase 2 Recruiting
240 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡